title: [Current aspects of laryngeal tuberculosis].
abstract: In the preantibiotic era laryngeal tuberculosis was the most frequent pathology of the larynx. In the last decades some changes in the presentation and evolution of the pathology have occurred due to the new chemiotherapy and the improvement of the nutrition. Actually it presents less incidence and infectivity and less evidence of pulmonary disease. In this article we analyse, on occasion of a clinical case and with a revision of the literature, the actual patterns of the laryngeal tuberculosis.
authors.affiliation: Ciudad Sanitaria y Universitaria de Bellvitge, Barcelona.
authors.forename: J
authors.initials: J
authors.lastname: Tornero Saltó
authors.forename: J J
authors.initials: JJ
authors.lastname: Nogués Orpí
authors.forename: X
authors.initials: X
authors.lastname: González Compta
authors.forename: E
authors.initials: E
authors.lastname: Cisa Lluís
authors.forename: I
authors.initials: I
authors.lastname: Doménech Juan
authors.forename: M
authors.initials: M
authors.lastname: Dicenta Sousa
mesh_terms: D000368:Aged; D000995:Antitubercular Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D007818:Laryngeal Diseases / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000382:microbiology; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification; D012293:Rifampin / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed; D014376:Tuberculosis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000382:microbiology
chemical_list: D000995:Antitubercular Agents; D007538:Isoniazid; D012293:Rifampin